Cargando…
(18)F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
PURPOSE: Rectal cancer is one of the most frequent causes of cancer-related morbidity and mortality in the world. Correct identification of the TNM state in primary staging of rectal cancer has critical implications on patient management. Initial evaluations revealed a high sensitivity and specifici...
Autores principales: | Gassert, Felix G., Rübenthaler, Johannes, Cyran, Clemens C., Rink, Johann S., Schwarze, Vincent, Luitjens, Johanna, Gassert, Florian T., Makowski, Marcus R., Schoenberg, Stefan O., Mayerhoefer, Marius E., Tamandl, Dietmar, Froelich, Matthias F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426298/ https://www.ncbi.nlm.nih.gov/pubmed/33686457 http://dx.doi.org/10.1007/s00259-021-05193-7 |
Ejemplares similares
-
Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
por: Gassert, Felix G., et al.
Publicado: (2021) -
Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma—A Cost-Effectiveness Analysis
por: Schnitzer, Moritz L., et al.
Publicado: (2020) -
Supplemental (18)F-FDG-PET/CT for Detection of Malignant Transformation of IPMN—A Model-Based Cost-Effectiveness Analysis
por: Bicu, Felix, et al.
Publicado: (2021) -
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis
por: Burian, Egon, et al.
Publicado: (2022) -
Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer
por: Herold, Alexander, et al.
Publicado: (2022)